ArticleNeuro-oncology advances

A single-center case study series assessing the effect of selumetinib use in patients with neurofibromatosis-related plexiform neurofibromas.

João Passos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.